Table 2-3.
Metabolomics and multi-omics in understanding the GI protective effects by polyphenols and polyphenolic-rich foods.
| Polyphenolic-rich foods | Technique | Experimental model and dosage | Major findings | References | |
|---|---|---|---|---|---|
 
 
 | 
Red wine and grape juice | 1H-NMR | 31 men and 22 women; mean SD age 57.6 ± 1.3 years; mildly hypertensive; non-smokers | The mixture of grape juice and wine extract induced a reduction in isobutyrate, indicate that polyphenols are able to modulate the microbial ecology of the gut | (152) | 
 
 | 
Black tea extract and red wine/grape juice extract | 1H-NMR | Five-stage in vitro GI model | BTE and RWGE modulate microbial SCFA production | (153) | 
| GC-MS | |||||
| LC-MS | |||||
 
 | 
Pomegranate | UPLC-ESI-QTOF-MS/MS | Colorectal cancer (CRC) patients | High punicalagin content hampered urolithins formation | (154) | 
 
 | 
Apple | 16S rRNA gene sequencing | SD rats | 127 proteins were differentially expressed and resulted in 123 fecal metabolites; there was a strong negative linear relationship between the relative abundance Firmicutes and Bacteroidetes in the high-fat group | (155) | 
| Mass spectrometry | |||||
| Gas chromatography time-of-flight mass spectrometry | |||||
 
 | 
Tart cherries | 16S rRNA gene sequencing LC/MS | In vitro incubations were performed by mimicking gastric, intestine and colon conditions | Resulted in large increases in Bacteroides and Collinsella, moderate increases of specific Firmicutes, Enterobacteriaceae and Bilophila | (156) | 
 
 | 
Rosemary | Microarray analysis 2-DE | Human HT29 colon cancer cell | Rosemary polyphenols against colon cancer cells | (157) | 
| MALDI-TOF/TOF-MS | |||||
| CE-MS | |||||
| UPLC-Q/TOF-MS | |||||
 
 | 
Mulberry Leaf | UPLC Triple TOF MS/MS | SD rats | Gut Environment is Altered by Mulberry Leaf | (158) | 
| GC-MS | |||||
| Dietary polyphenols | CE-TOF MS | Human HT29 colon cancer cells | Reduced glutathione/oxidized glutathione ratio and significant alterations in polyamines content | (26) | |
| RP/UPLC-TOF MS | |||||
| HILIC/UPLC-TOF MS | |||||